Skip to content

Author

A. Naleway

We have 6 of 369 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Meningococcal B Vaccination Patterns Across 10 Integrated Health Systems within Vaccine Safety Datalink, 2015-2023.

OBJECTIVE To examine patterns of vaccination with the meningococcal B vaccine (MenB) across 10 Vaccine Safety Datalink (VSD) healthcare systems. STUDY DESIGN We identified all MenB doses administered 2015-2023 to individuals ages 10-25 years at VSD sites. Each site was assigned to a US region: Western, Central, or Ea...

H. Groom, Neon B. Brooks, Padmavati Dandamudi et al. · 0 citations
Aug 2026

Effectiveness of RSV Prevention Strategies in US Infants: 2024-2025.

Nirsevimab and maternal RSV vaccination were effective against RSV-associated ED encounters and hospitalization among infants in their first RSV season, and monitoring infant RSV immunization effectiveness remains important.

A. Payne, S. Battan-Wraith, S. E. Reese et al. · 0 citations
Open access Aug 2026

Influenza Vaccine Effectiveness Against Influenza-Associated Hospitalizations and Emergency Department or Urgent Care Encounters Among Children and Adults-VISION, United States, 2024-2025 Season.

Findings support influenza vaccination as an important tool to reduce influenza in children and adults in the US during the severe 2024-2025 influenza season.

J. DeCuir, Emily L. Reeves, Zachary A. Weber et al. · 0 citations
Open access Jul 2026

Immune correlates of risk for SARS-CoV-2 infection in children: a prospective, community-based cohort study

It is revealed that higher nucleocapsid-binding and Omicron-specific neutralizing antibodies significantly reduce infection risk, suggesting these markers could guide tailored vaccination strategies and risk assessments in pediatric populations.

K. Hoffman, Grace Marshall, C. Frivold et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.